M&A Deal Summary

Telegraph Hill Partners Acquires Dynex Technologies

On March 31, 2017, venture capital firm Telegraph Hill Partners acquired medical products company Dynex Technologies from Ampersand Capital Partners

Acquisition Highlights
  • This is Telegraph Hill Partners’ 13th transaction in the Medical Products sector.
  • This is Telegraph Hill Partners’ 21st transaction in the United States.
  • This is Telegraph Hill Partners’ 1st transaction in Virginia.

M&A Deal Summary

Date 2017-03-31
Target Dynex Technologies
Sector Medical Products
Buyer(s) Telegraph Hill Partners
Sellers(s) Ampersand Capital Partners
Deal Type Secondary Buyout

Target

Dynex Technologies

Chantilly, Virginia, United States
website
Dynex Technologies, Inc. is a designer and manufacturer of fully-automated ELISA microplate workstations, laboratory instruments, and associated consumables and accessories, seamlessly integrating advanced detection with fully-automated sample handling. Dynex Technologies was established in 1952 and is based in Chantilly, Virginia.

Search 173,065 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Telegraph Hill Partners

San Francisco, California, United States

Investor Investor Investor Investor Investor

website


Category Venture Capital Firm
Founded 2001
SizeMiddle-Market
Type Sector Focused
DESCRIPTION

Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.


DEAL STATS #
Overall 24 of 32
Sector (Medical Products) 13 of 17
Type (Secondary Buyout) 1 of 1
State (Virginia) 1 of 1
Country (United States) 21 of 29
Year (2017) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-15 TrakCel

Cardiff, United Kingdom

TrakCel Ltd. is a provider of cellular orchestration technology to aid in the delivery of regenerative therapies. TrakCel's cell, gene, and immunotherapy management solution improves clinical study efficacy and accelerates global scale-up and scale-out by implementing communications technology to integrate the delivery path from needle-to-needle. TrakCel was established in 2012 and is based in Cardiff, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-24 Verogen

San Diego, California, United States

Verogen, Inc. is a developer, manufacturer, and sells forensic genomics products and services, including for next-generation sequencing. Verogen was formed in 2017 and is based in San Diego, California.

Buy -

Seller(S) 1

SELLER

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

website


Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
SizeLarge
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


DEAL STATS #
Overall 32 of 49
Sector (Medical Products) 10 of 13
Type (Secondary Buyout) 3 of 4
State (Virginia) 1 of 1
Country (United States) 32 of 48
Year (2017) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-03-07 Genoptix

Carlsbad, California, United States

Genoptix, Inc. is one of the largest hematopathology testing laboratories in the U.S., providing thousands of oncologists and pathologists across the United States with comprehensive testing solutions in hematology and solid tumor molecular profiling. Genoptix, Inc. was founded in 1999 and is based in Carlsbad, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-10 Roadrunner Pharmacy

Phoenix, Arizona, United States

Roadrunner Pharmacy, Inc. is a provider of technology-enabled healthcare services for companion and equine veterinary practitioners. Roadrunner Pharmacy, Inc. was established in 1999 and is based in Phoenix, Arizona.

Sell -